Navigating Growth: Opportunities and Challenges in Healthcare Analytical Testing Services
https://www.marketsandmarkets.....com/Market-Reports/h
The Healthcare analytical testing services Market is projected to reach a valuation of USD 7.4 billion in 2024, with an anticipated surge to USD 12.6 billion by 2029, exhibiting a CAGR of 11.2% throughout the forecast period. Growth in the Healthcare analytical testing services Market is mainly driven by factors such as Growing pharmaceutical and biopharmaceutical R & D activities, stringent regulatory requirements, rising number of clinical trials, growing focus on biosimilars and biologics and rising acceptance of QbD approach in pharma research and manufacturing. However, lack of skilled professionals and rising costs and market competition can negatively affect growth of the market during the forecast period.
The prominent players in the global healthcare analytical testing services market include Eurofins Scientific (Luxembourg), Laboratory Corporation of America Holdings (US), SGS S.A. (Switzerland), Charles River Laboratories (US), WuXi AppTec Co. Ltd. (China), Element Materials Technology (UK), Thermo Fisher Scientific, Inc. (US), Pace Analytical Services LLC (US), Intertek Group plc (UK), IQVIA Inc. (US), Merck KGaA (Germany), Source BioScience (UK), Almac Group (UK), ICON Plc (Ireland), Frontage Laboratories, Inc. (US), STERIS Plc (US), Sartorius AG (Germany), ALS Life Science (US), Syneos Health, INC (US), Medpace Holdings, Inc. (US), LGC Limited (UK), Parexel International Corporation (US), Celerion (US). Pharmaron (China), and BioAgilytix Labs (US).
